NeoGenomics, Inc. Equity-NMS: NEO

Healthcare

Diagnostics & Research

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :	$17.9
Open :	$17.72
Today's high :	$18.02
Today's low :	$17.47
52W low :	$12.77
52W high :	$21.22
1Y :	-10.75%
5Y :	-33.8%
EPS(TTM): :	-0.6
Shares O/S :	128.36 M
Market cap :	2.28 B

What is the share price of NeoGenomics, Inc. today?

NeoGenomics, Inc. (NEO) share price as of December 15, 2024, is $17.73. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of NeoGenomics, Inc.?

Yes, Indian Investors can invest in the NeoGenomics, Inc. (NEO) Share by opening an international trading account with Angel One.

How can I purchase NeoGenomics, Inc. shares in India?

Purchasing NeoGenomics, Inc. (NEO) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying NeoGenomics, Inc. (NEO) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of NeoGenomics, Inc.?

Yes, you can purchase fractional shares of NeoGenomics, Inc. (NEO) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of NeoGenomics, Inc.?

The market capitalization of NeoGenomics, Inc. on December 15, 2024, is $2.28 B.

In which sector NeoGenomics, Inc. belongs?

NeoGenomics, Inc. operates in the Healthcare sector, specifically in the Diagnostics & Research industry.

What documents are required to invest in NeoGenomics, Inc. stocks?

In order to invest in NeoGenomics, Inc. (NEO) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

NeoGenomics, Inc. provides a range of oncology diagnostic testing and consultative services which includes technical laboratory services. The Company offers professional interpretation of laboratory test results by licensed physicians who specialize in pathology and oncology. Its segments include Clinical Services and Advanced Diagnostics. The Clinical Services segment consists of clinical cancer testing; interpretation and consultative services; molecular and NGS testing, and comprehensive technical and professional services offering. Its Clinical Services customers include community-based pathology and oncology practices, hospital pathology labs, reference labs, and academic centers. The Advanced Diagnostics segment consist of clinical trials and research, validation laboratory services, and informatics. Its Advanced Diagnostics customers include pharmaceutical companies to whom it provides testing and other services to support their research studies and clinical trials.